Atlas Trials

Efficacy Study of Thymosin alpha1 & Pegylated Interferon-alpha2a to Treat Chronic Hepatitis B

Clinical trial NCT00291616 · COMPLETED

Trial details

NCT number
NCT00291616
Sponsor
Seoul National University Hospital
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Chronic Hepatitis B
Start date
2005-12-01
Primary completion
2008-08-01
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.